A brilliant fund house at a borrowed price
SBI Funds Management is everything you want in an AMC — India's largest by mutual-fund AUM, a 1.5-crore SIP engine, 79% operating margins, zero debt. The business is not the problem. The price is. The unlisted market has already run from ₹900 to ₹2,800, handed early holders a 3:1 bonus, and now sits at ₹858 — a valuation that bakes in an IPO that hasn't priced yet. This note is a caution: the easy money here was made two years ago, not today.
Nothing wrong with the company
Let's be clear up front — the quality is real. SBI Funds is a market leader with a recurring, asset-light, high-margin model that compounds quietly as India keeps putting money into SIPs.
Market leadership (15.4% share), 1.80 crore investors, 1.576 crore live SIPs, and a rising equity mix (46% of MF QAAUM, up from 42% in FY24) that lifts fee realisation. Zero borrowings. This is a genuinely excellent financial-services business. The debate is not quality — it's what you pay for it.
| Particular | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue | 2,303 | 3,273 | 4,063 | 4,390 |
| EBITDA | 1,701 | 2,566 | 3,239 | 3,472 |
| Operating margin | 73.9% | 78.4% | 79.7% | 79.1% |
| Other income | 109 | 165 | 187 | 601 |
| PAT | 1,340 | 2,073 | 2,540 | 3,067 |
| Net profit margin | 58.2% | 63.3% | 62.5% | 69.9% |
| EPS (₹) | 26.64 | 40.98 | 50.02 | 15.06* |
*FY26 EPS reflects the 3:1 bonus (share count ×4); on a comparable pre-bonus basis it is ~₹60. PAT compounded at ~32% a year over FY23–FY26 — strong, though FY26 was helped by a jump in other income to ₹601 Cr.
From ₹900 to ₹2,800 — then a bonus reset
Here's the journey that matters. The story the unlisted market tells you today (₹858) hides a price that already tripled and was then split by a bonus issue. Read it carefully before you assume there's another triple ahead.
The early crowd did very well
If you bought one share in 2023 at ₹900, the 3:1 bonus turned it into four shares. At ₹858 each, those four are worth ₹3,432 — before counting any dividends.
That is a superb outcome from an unlisted holding — roughly 3.8x in three years, driven by both earnings growth and a steep re-rating as IPO expectations built. The unlisted market worked for these investors. The uncomfortable question for a new buyer in June 2026 is simple: who's left to pay you a higher price, and at what IPO valuation?
What you pay vs what the IPO is likely to fetch
At ₹858, SBI Funds is valued at ₹1,74,298 crore — a P/E of ~57x. Our read on where the IPO actually prices is materially lower: a fair band of ₹1.20–1.25 lakh crore. That's the gap that should worry a new entrant.
| Scenario | Market cap | Per share | P/E (FY26) | vs ₹858 |
|---|---|---|---|---|
| Unlisted price today | ₹1,74,298 Cr | ₹858 | 56.8× | — |
| Fair IPO value (high) | ₹1,25,000 Cr | ₹615 | 40.8× | −28% |
| Fair IPO value (low) | ₹1,20,000 Cr | ₹591 | 39.1× | −31% |
Even a fair value at the top of that band — ₹1.25 lakh crore — implies the unlisted price is roughly 28–31% above where the IPO is likely to land. And ~40x earnings is already a full multiple for an AMC: it sits above HDFC AMC (~41x) and Nippon (~49x) only because of the SBI brand and scale premium. There isn't much headroom left to pay up for.
| Fund house | AUM | P/E | MCap / AUM |
|---|---|---|---|
| UTI AMC | ₹3.8L Cr | ~26× | 3.2% |
| PPFAS AMC | ₹1.6L Cr | 39.7× | 8.6% |
| HDFC AMC | ₹9.3L Cr | ~41× | 12.5% |
| Nippon India AMC | ₹7.7L Cr | ~49× | 9.8% |
| SBI Funds (at ₹858) | ₹12.5L Cr | 56.8× | 13.9% |
Why ₹858 leaves little on the table
An unlisted buyer makes money in one of two ways: the company grows earnings, or the market re-rates the multiple upward. At ₹858, both levers are largely spent.
The late entrant
The early entrant
The early buyer caught the re-rating and the growth. The late buyer at ₹858 has bought the re-rating already done — so even if PAT keeps compounding at ~20%, a de-rating to IPO levels can quietly cancel a year or two of that growth. You can be right about the business and still lose money on the entry price.
The unlisted playbook: enter early, let it grow into the multiple
The whole point of buying unlisted is to get in 2–3 years before the IPO — while revenue and PAT are still climbing — so that by listing day the company has grown into a premium multiple and you capture both the earnings growth and the IPO-hype re-rating. Buying in the final pre-IPO months inverts that edge.
SBI Funds, for real — two entry timings
Not a hypothetical. These are SBI's own audited numbers. The early buyer paid ~34x in 2023; the buyer today pays 57x. Same company, same compounding — only the entry price differs.
| What you capture | Enter 2023 | Enter today |
|---|---|---|
| Entry price | ₹900 | ₹858 |
| EPS at entry | ₹26.64 | ₹15.06* |
| Entry P/E paid | 33.8× | 57.0× |
| PAT at entry → FY26 | ₹1,340 → 3,067 Cr | already ₹3,067 Cr |
| Likely IPO P/E | ~40× | ~40× |
| Your return | ≈ +281% | ≈ −28 to −31% |
The 2023 entrant earns +281% (3.8x) — about +126% from earnings (EPS ₹26.64 → ₹60.24 bonus-adjusted) plus +69% from the multiple re-rating (34x → 57x), magnified by the 3:1 bonus. The buyer today pays 57x for the same business; when the IPO prices near 40x (₹1.20–1.25 lakh Cr), the multiple de-rates and the position is underwater by ~30% — even though PAT has compounded at ~32% a year. Timing, not the business, decides the outcome.
*FY26 EPS of ₹15.06 is post the 3:1 bonus (share count ×4); the bonus-adjusted figure comparable to earlier years is ~₹60.
What could go wrong from here
A premium price gives you no cushion if any of these bite:
| Risk | Why it matters at ₹858 |
|---|---|
| IPO prices below the unlisted quote | Fair value ₹1.20–1.25L Cr vs ₹1.74L Cr implies a ~28–31% reset at listing. |
| SEBI expense framework (Apr 2026) | Revised TER rules can compress fees — the core revenue lever for any AMC. |
| Market dependence | Revenue is tied to AUM; an equity drawdown hits fee income directly. |
| Pure Offer-for-Sale | No fresh capital enters the company; proceeds go to SBI and Amundi selling down. |
| Other income quality | FY26 PAT was flattered by ₹601 Cr of other income — strip it and core growth looks calmer. |
| Scheme concentration | Top 10 schemes are ~60% of MF QAAUM. |
Right business, wrong entry point
SBI Funds Management is a high-quality, market-leading AMC, and investors who entered the unlisted market in 2023–24 have been richly rewarded — roughly 3.8x in three years through a re-rating and a 3:1 bonus. That is exactly how the unlisted game is supposed to work: get in early, let revenue and PAT grow, and let the IPO hype hand you a premium multiple.
But that window has closed. At ₹858 the share already trades at ~57x earnings and ~30% above where we think the IPO will price (₹1.20–1.25 lakh crore, ~40x). A new buyer today is paying peak-hype valuation for a pure offer-for-sale, with regulatory fee pressure looming and little multiple headroom left. The likely outcome is that the listing resets the price down toward fair value rather than rewarding the latecomer.
For new investors: don't chase it here. Either wait for the IPO and judge it on the final pricing, or look for the next SBI-Funds-shaped opportunity 2–3 years before its IPO — that's where the asymmetric money is made, not at the finish line.
Not investment advice. Figures from the SBI Funds DRHP (19 Mar 2026), company disclosures, unlisted-market quotes, and AMC peer data. Unlisted prices are indicative and illiquid; IPO terms and pricing may change. Read the offer document and consult a registered advisor before investing.